NovaBay Pharmaceuticals, Inc.
(NYSE Amex Equities : NBY)

( )
NBY After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-1.67%292.231.4%$590.52m
AMGNAmgen, Inc.
0.07%234.011.3%$503.19m
GILDGilead Sciences, Inc.
1.04%67.781.0%$366.31m
REGNRegeneron Pharmaceuticals, Inc.
1.59%373.532.6%$302.52m
VRTXVertex Pharmaceuticals, Inc.
-0.12%220.001.9%$273.01m
ILMNIllumina, Inc.
-1.95%320.573.5%$231.88m
ARWRArrowhead Pharmaceuticals, Inc.
-3.73%68.2211.4%$207.81m
CLVSClovis Oncology, Inc.
-3.14%11.7214.7%$207.81m
ALXNAlexion Pharmaceuticals, Inc.
-1.53%109.502.0%$195.03m
EXASEXACT Sciences Corp.
-0.15%85.1724.0%$163.33m
AAgilent Technologies, Inc.
0.60%83.431.6%$159.09m
GBTGlobal Blood Therapeutics, Inc.
3.29%78.456.0%$142.09m
BLUEbluebird bio, Inc.
1.49%86.9714.2%$139.80m
BOLDAudentes Therapeutics, Inc.
-0.12%59.441.4%$134.26m
SGENSeattle Genetics, Inc.
-2.32%111.346.1%$128.54m

Company Profile

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.